Methyltestosterone

CAS number: 58-18-4

General information about the Methyltestosterone active pharmaceutical ingredient

ethyltestosterone as active pharmaceutical ingredient (API) is a synthetic anabolic steroid used to treat low testosterone levels in males and certain types of breast cancer in women. Methyltestosterone is used to treat hypogonadism in males and in females Methyltestosterone treats breast pain, swelling due to pregnancy, and with the addition of estrogen it can treat symptoms of menopause. Methyltestosterone is also used to induce puberty in adolescent boys with delayed puberty and as a component of menopausal hormone therapy for menopausal symptoms like hot flashes, osteoporosis in girls. Methyltestosterone comes as oral tablets and capsules.

Axplora manufactures Methyltestosterone API

Methyltestosterone API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Methyltestosterone API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Methyltestosterone API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Methyltestosterone API.
  • Therapeutic area Anabolic-
    Androgenic
  • Monograph PH.EUR.
    USP
  • Available grade Micronized
  • Regulatory documentation EU DMF
    US DMF#
  • Produced in GRO